Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point

Recurrent mutations in the spliceosome are observed in several human cancers, but their functional and therapeutic significance remains elusive. SF3B1, the most frequently mutated component of the spliceosome in cancer, is involved in the recognition of the branch point sequence (BPS) during selecti...

Full description

Bibliographic Details
Main Authors: Rachel B. Darman, Michael Seiler, Anant A. Agrawal, Kian H. Lim, Shouyong Peng, Daniel Aird, Suzanna L. Bailey, Erica B. Bhavsar, Betty Chan, Simona Colla, Laura Corson, Jacob Feala, Peter Fekkes, Kana Ichikawa, Gregg F. Keaney, Linda Lee, Pavan Kumar, Kaiko Kunii, Crystal MacKenzie, Mark Matijevic, Yoshiharu Mizui, Khin Myint, Eun Sun Park, Xiaoling Puyang, Anand Selvaraj, Michael P. Thomas, Jennifer Tsai, John Y. Wang, Markus Warmuth, Hui Yang, Ping Zhu, Guillermo Garcia-Manero, Richard R. Furman, Lihua Yu, Peter G. Smith, Silvia Buonamici
Format: Article
Language:English
Published: Elsevier 2015-11-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124715010785
id doaj-ff6c0ceb5e1f4d5b93d3d3ccbbf6a31c
record_format Article
spelling doaj-ff6c0ceb5e1f4d5b93d3d3ccbbf6a31c2020-11-24T21:27:49ZengElsevierCell Reports2211-12472015-11-011351033104510.1016/j.celrep.2015.09.053Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch PointRachel B. Darman0Michael Seiler1Anant A. Agrawal2Kian H. Lim3Shouyong Peng4Daniel Aird5Suzanna L. Bailey6Erica B. Bhavsar7Betty Chan8Simona Colla9Laura Corson10Jacob Feala11Peter Fekkes12Kana Ichikawa13Gregg F. Keaney14Linda Lee15Pavan Kumar16Kaiko Kunii17Crystal MacKenzie18Mark Matijevic19Yoshiharu Mizui20Khin Myint21Eun Sun Park22Xiaoling Puyang23Anand Selvaraj24Michael P. Thomas25Jennifer Tsai26John Y. Wang27Markus Warmuth28Hui Yang29Ping Zhu30Guillermo Garcia-Manero31Richard R. Furman32Lihua Yu33Peter G. Smith34Silvia Buonamici35H3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USADepartment of Hematology/Oncology, Weill Cornell Medical College, New York, NY 10020, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USADepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAEisai, Inc., Andover, MA 01810, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAEisai, Inc., Andover, MA 01810, USAEisai, Inc., Andover, MA 01810, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAEisai, Inc., Andover, MA 01810, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USADepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USADepartment of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USADepartment of Hematology/Oncology, Weill Cornell Medical College, New York, NY 10020, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USAH3 Biomedicine, Inc., Cambridge, MA 02139, USARecurrent mutations in the spliceosome are observed in several human cancers, but their functional and therapeutic significance remains elusive. SF3B1, the most frequently mutated component of the spliceosome in cancer, is involved in the recognition of the branch point sequence (BPS) during selection of the 3′ splice site (ss) in RNA splicing. Here, we report that common and tumor-specific splicing aberrations are induced by SF3B1 mutations and establish aberrant 3′ ss selection as the most frequent splicing defect. Strikingly, mutant SF3B1 utilizes a BPS that differs from that used by wild-type SF3B1 and requires the canonical 3′ ss to enable aberrant splicing during the second step. Approximately 50% of the aberrantly spliced mRNAs are subjected to nonsense-mediated decay resulting in downregulation of gene and protein expression. These findings ascribe functional significance to the consequences of SF3B1 mutations in cancer.http://www.sciencedirect.com/science/article/pii/S2211124715010785
collection DOAJ
language English
format Article
sources DOAJ
author Rachel B. Darman
Michael Seiler
Anant A. Agrawal
Kian H. Lim
Shouyong Peng
Daniel Aird
Suzanna L. Bailey
Erica B. Bhavsar
Betty Chan
Simona Colla
Laura Corson
Jacob Feala
Peter Fekkes
Kana Ichikawa
Gregg F. Keaney
Linda Lee
Pavan Kumar
Kaiko Kunii
Crystal MacKenzie
Mark Matijevic
Yoshiharu Mizui
Khin Myint
Eun Sun Park
Xiaoling Puyang
Anand Selvaraj
Michael P. Thomas
Jennifer Tsai
John Y. Wang
Markus Warmuth
Hui Yang
Ping Zhu
Guillermo Garcia-Manero
Richard R. Furman
Lihua Yu
Peter G. Smith
Silvia Buonamici
spellingShingle Rachel B. Darman
Michael Seiler
Anant A. Agrawal
Kian H. Lim
Shouyong Peng
Daniel Aird
Suzanna L. Bailey
Erica B. Bhavsar
Betty Chan
Simona Colla
Laura Corson
Jacob Feala
Peter Fekkes
Kana Ichikawa
Gregg F. Keaney
Linda Lee
Pavan Kumar
Kaiko Kunii
Crystal MacKenzie
Mark Matijevic
Yoshiharu Mizui
Khin Myint
Eun Sun Park
Xiaoling Puyang
Anand Selvaraj
Michael P. Thomas
Jennifer Tsai
John Y. Wang
Markus Warmuth
Hui Yang
Ping Zhu
Guillermo Garcia-Manero
Richard R. Furman
Lihua Yu
Peter G. Smith
Silvia Buonamici
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
Cell Reports
author_facet Rachel B. Darman
Michael Seiler
Anant A. Agrawal
Kian H. Lim
Shouyong Peng
Daniel Aird
Suzanna L. Bailey
Erica B. Bhavsar
Betty Chan
Simona Colla
Laura Corson
Jacob Feala
Peter Fekkes
Kana Ichikawa
Gregg F. Keaney
Linda Lee
Pavan Kumar
Kaiko Kunii
Crystal MacKenzie
Mark Matijevic
Yoshiharu Mizui
Khin Myint
Eun Sun Park
Xiaoling Puyang
Anand Selvaraj
Michael P. Thomas
Jennifer Tsai
John Y. Wang
Markus Warmuth
Hui Yang
Ping Zhu
Guillermo Garcia-Manero
Richard R. Furman
Lihua Yu
Peter G. Smith
Silvia Buonamici
author_sort Rachel B. Darman
title Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
title_short Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
title_full Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
title_fullStr Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
title_full_unstemmed Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3′ Splice Site Selection through Use of a Different Branch Point
title_sort cancer-associated sf3b1 hotspot mutations induce cryptic 3′ splice site selection through use of a different branch point
publisher Elsevier
series Cell Reports
issn 2211-1247
publishDate 2015-11-01
description Recurrent mutations in the spliceosome are observed in several human cancers, but their functional and therapeutic significance remains elusive. SF3B1, the most frequently mutated component of the spliceosome in cancer, is involved in the recognition of the branch point sequence (BPS) during selection of the 3′ splice site (ss) in RNA splicing. Here, we report that common and tumor-specific splicing aberrations are induced by SF3B1 mutations and establish aberrant 3′ ss selection as the most frequent splicing defect. Strikingly, mutant SF3B1 utilizes a BPS that differs from that used by wild-type SF3B1 and requires the canonical 3′ ss to enable aberrant splicing during the second step. Approximately 50% of the aberrantly spliced mRNAs are subjected to nonsense-mediated decay resulting in downregulation of gene and protein expression. These findings ascribe functional significance to the consequences of SF3B1 mutations in cancer.
url http://www.sciencedirect.com/science/article/pii/S2211124715010785
work_keys_str_mv AT rachelbdarman cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT michaelseiler cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT anantaagrawal cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT kianhlim cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT shouyongpeng cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT danielaird cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT suzannalbailey cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT ericabbhavsar cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT bettychan cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT simonacolla cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT lauracorson cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT jacobfeala cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT peterfekkes cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT kanaichikawa cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT greggfkeaney cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT lindalee cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT pavankumar cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT kaikokunii cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT crystalmackenzie cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT markmatijevic cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT yoshiharumizui cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT khinmyint cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT eunsunpark cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT xiaolingpuyang cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT anandselvaraj cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT michaelpthomas cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT jennifertsai cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT johnywang cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT markuswarmuth cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT huiyang cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT pingzhu cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT guillermogarciamanero cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT richardrfurman cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT lihuayu cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT petergsmith cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
AT silviabuonamici cancerassociatedsf3b1hotspotmutationsinducecryptic3splicesiteselectionthroughuseofadifferentbranchpoint
_version_ 1725973254498156544